9.9  References

Adams 2005  
Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Beclomethasone versus placebo for chronic asthma. Cochrane Database of Systematic Reviews 2005, Issue 1. Art No: CD002738.

Agresti 1996  
Agresti A. An introduction to categorical data analysis. New York (NY): John Wiley & Sons, 1996.

Altman 1996  
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996; 313: 1200-1200.

Antman 1992  
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA 1992; 268: 240-248.

Berlin 1993  
Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993; 4: 218-228.

Berlin 1994  
Berlin JA, Antman EM. Advantages and limitations of metaanalytic regressions of clinical trials data. Online Journal of Current Clinical Trials 1994; Doc No 134.

Berlin 2002  
Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman KA. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Statistics in Medicine 2002; 21: 371-387.

Borenstein 2008  
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. Chichester (UK): John Wiley & Sons, 2008.

Bradburn 2007  
Bradburn MJ, Deeks JJ, Berlin JA, Russell LA. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Statistics in Medicine 2007; 26: 53-77.

Chinn 2000  
Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Statistics in Medicine 2000; 19: 3127-3131.

Cooper 1980  
Cooper HM, Rosenthal R. Statistical versus traditional procedures for summarizing research findings. Psychological Bulletin 1980; 87: 442-449.

Crawford 2007  
Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the feet. Cochrane Database of Systematic Reviews 2007, Issue 3. Art No: CD001434.

Deeks 1998  
Deeks JJ. Systematic reviews of published evidence: Miracles or minefields? Annals of Oncology 1998; 9: 703-709.

Deeks 2001  
Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (editors). Systematic Reviews in Health Care: Meta-analysis in Context (2nd edition). London (UK): BMJ Publication Group, 2001.

Deeks 2002  
Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2002; 21: 1575-1600.

DerSimonian 1986  
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-188.

Egger 1997  
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.

Engels 2000  
Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Statistics in Medicine 2000; 19: 1707-1728.

Greenland 1985  
Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55-68.

Greenland 1987  
Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiologic Reviews 1987; 9: 1-30.

Greenland 1992  
Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. American Journal of Epidemiology 1992; 135: 1301-1309.

Hasselblad 1995  
Hasselblad VIC, Mccrory DC. Meta-analytic tools for medical decision making: A practical guide. Medical Decision Making 1995; 15: 81-96.

Higgins 2002  
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002; 21: 1539-1558.

Higgins 2003  
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.

Higgins 2004  
Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Statistics in Medicine 2004; 23: 1663-1682.

Higgins 2008a
Higgins JPT, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales.
Statistics in Medicine 2008; 27: 6072-6092.

Higgins 2008b
Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis.
Journal of the Royal Statistical Society Series A, 2008 (published online ahead of print 24 Jul 2008).

Kjaergard 2001  
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001; 135: 982-989.

Laupacis 1988  
Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. New England Journal of Medicine 1988; 318: 1728-1733.

Mantel 1959  
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959; 22: 719-748.

McIntosh 1996  
McIntosh MW. The population risk as an explanatory variable in research synthesis of clinical trials. Statistics in Medicine 1996; 15: 1713-1728.

Moher 2005  
Moher M, Hey K, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. Art No: CD003440.

Morgenstern 1982  
Morgenstern H. Uses of ecologic analysis in epidemiologic research. American Journal of Public Health 1982; 72: 1336-1344.

O'Rourke 1989  
O'Rourke K, Detsky AS. Meta-analysis in medical research: strong encouragement for higher quality in individual research efforts. Journal of Clinical Epidemiology 1989; 42: 1021-1026.

Oxman 1992  
Oxman AD, Guyatt GH. A consumers guide to subgroup analyses. Annals of Internal Medicine 1992; 116: 78-84.

Pittler 2003  
Pittler MH, Ernst E. Kava extract versus placebo for treating anxiety. Cochrane Database of Systematic Reviews 2003, Issue 1. Art No: CD003383.

Poole 1999  
Poole C, Greenland S. Random-effects meta-analyses are not always conservative. American Journal of Epidemiology 1999; 150: 469-475.

Sackett 1996  
Sackett DL, Deeks JJ, Altman DG. Down with odds ratios! Evidence Based Medicine 1996; 1: 164-166.

Sackett 1997  
Sackett DL, Richardson WS, Rosenberg W, Haynes BR. Evidence-Based Medicine: How to Practice and Teach EBM. Edinburgh (UK): Churchill Livingstone, 1997.

Sharp 2000  
Sharp SJ. Analysing the relationship between treatment benefit and underlying risk: precautions and practical recommendations. In: Egger M, Davey Smith G, Altman DG (editors). Systematic Reviews in Health Care: Meta-analysis in Context (2nd edition). London (UK): BMJ Publication Group, 2000.

Sinclair 1994  
Sinclair JC, Bracken MB. Clinically useful measures of effect in binary analyses of randomized trials. Journal of Clinical Epidemiology 1994; 47: 881-889.

Thompson 1997  
Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Statistics in Medicine 1997; 16: 2741-2758.

Thompson 1999  
Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Statistics in Medicine 1999; 18: 2693-2708.

Thompson 2002  
Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Statistics in Medicine 2002; 21: 1559-1574.

Whitehead 1991  
Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Statistics in Medicine 1991; 10: 1665-1677.

Whitehead 1994  
Whitehead A, Jones NMB. A meta-analysis of clinical trials involving different classifications of response into ordered categories. Statistics in Medicine 1994; 13: 2503-2515.

Yusuf 1985  
Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Progress in Cardiovascular Diseases 1985; 27: 335-371.

Yusuf 1991  
Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991; 266: 93-98.